Details for New Drug Application (NDA): 018733
✉ Email this page to a colleague
The generic ingredient in TALWIN NX is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
Summary for 018733
Tradename: | TALWIN NX |
Applicant: | Sanofi Aventis Us |
Ingredient: | naloxone hydrochloride; pentazocine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 16, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018733
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TALWIN NX | naloxone hydrochloride; pentazocine hydrochloride | TABLET;ORAL | 018733-001 | Dec 16, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription